hemay007
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 9, 2017 (NCT02603185)
Timeline
Indications
Mechanism of action
- TNF-alphaINHIBITOR
TNF inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hemay007
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05247216 | Phase 2 | Mar 26, 2021 | Hemay Pharmaceutical PTY. LTD., Southern Medical University |
| NCT03977480 | Phase 2 | Jun 1, 2019 | Hemay Pharmaceutical PTY. LTD., Xijing Hospital |
| NCT02603185 | Phase 1 | Jan 9, 2017 | Hemay Pharmaceutical PTY. LTD. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hemay Pharmaceutical PTY. LTD. | For profit | 3 | 3 | 2 | 2017 |
| Southern Medical University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Xijing Hospital | Academic/Hospital | 1 | 0 | 1 | 2019 |
3 organizations
Page 1 / 1